Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.580
0.00 (0.00%)
At close: Jul 2, 2026, 4:00 PM EDT
1.600
+0.020 (1.27%)
After-hours: Jul 2, 2026, 7:49 PM EDT
Autolus Therapeutics Market Cap
Autolus Therapeutics has a market cap or net worth of $420.51 million as of July 2, 2026. Its market cap has decreased by -22.17% in one year.
Market Cap
420.51M
Enterprise Value
560.20M
1-Year Change
-22.17%
Ranking
Category
Stock Price
$1.58
Market Cap Chart
Since June 22, 2018, Autolus Therapeutics's market cap has decreased from $944.40M to $420.51M, a decrease of -55.47%. That is a compound annual growth rate of -9.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 420.50M | -20.60% |
| Dec 31, 2025 | 529.60M | -15.32% |
| Dec 31, 2024 | 625.40M | -44.19% |
| Dec 29, 2023 | 1.12B | 546.94% |
| Dec 30, 2022 | 173.20M | -54.23% |
| Dec 31, 2021 | 378.40M | -19.08% |
| Dec 31, 2020 | 467.60M | -21.25% |
| Dec 31, 2019 | 593.80M | -54.96% |
| Dec 31, 2018 | 1.32B | 39.60% |
| Jun 22, 2018 | 944.40M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enanta Pharmaceuticals | 439.37M |
| Century Therapeutics | 438.26M |
| vTv Therapeutics | 437.56M |
| Eupraxia Pharmaceuticals | 428.28M |
| Puma Biotechnology | 420.43M |
| Rocket Pharmaceuticals | 419.30M |
| DiaMedica Therapeutics | 410.59M |
| Compass Therapeutics | 408.80M |